Pragmatic clinical trial demonstrates greater BMI reduction and higher remission with add-on digital tools in pediatric obesity, suggesting durable benefits of combined digi-physical care.
BACKGROUND: The integration of mobile health technology with physical visits shows promising one-year treatment outcomes, but long-term evidence is lacking. OBJECTIVES: To assess three-year treatment outcomes for patients utilizing the digital treatment tool Evira in combination with physical visits, compared with standard obesity care. METHODS: In a pragmatic trial, children with obesity aged 4.0-17.9 years receiving digi-physical treatment with Evira (n = 107) were compared with a group receiving standard treatment (n = 321). Evira comprises a digitless body scale for home-weighing, a mobile application, and a web-based clinic interface, enabling easy family-clinic communication and continuous visual treatment feedback. RESULTS: At the three-year follow-up, the adjusted average change in body mass index Z-score was -0.29 [95% confidence interval: -0.40, -0.18] units in the digi-physical treatment group vs. -0.12 [-0.21, -0.03] in the standard treatment group, p = 0.02, and 31.8% vs. 18.7% obtained obesity remission respectively, p = 0.0046. CONCLUSION: Over a three-year period, the digi-physical treatment generated superior treatment effect and higher obesity remission rate than standard treatment.
No takes yet. Share an insight, caveat, or question.
Hagman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: